Jasper Therapeutics, Inc. (NASDAQ: JSPR) Investor Alert: Deadline in Lawsuit on November 18, 2025

A deadline is coming up on November 18, 2025 in the lawsuit filed for certain investors of Jasper Therapeutics, Inc. (NASDAQ: JSPR) over alleged securities laws violations by Jasper Therapeutics, Inc.

Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and there are strict and short deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Jasper Therapeutics, Inc. (NASDAQ: JSPR) common shares between November 30, 2023 and July 3, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 30, 2023 and July 3, 2025, the Defendants made false and/or misleading statements and/or failed to disclose that Jasper Therapeutics, Inc. lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials, that the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab, that the foregoing increased the likelihood of disruptive cost-reduction measures, that accordingly, the Company's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.